This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
$0.03545
Share price
0.00%
Change (1 day)
-99.24%
Change (1 year)
Categories
EPS for ViewRay (VRAY)
EPS in 2023 (TTM): -$0.80
According to ViewRay's latest financial reports the company's current EPS (TTM) is -$0.85. In 2022 the company made an earnings per share (EPS) of -$0.82 an increase over its 2021 EPS that were of -$0.95.
EPS history for ViewRay from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.80 | -2.17% |
| 2022 | -$0.82 | -13.43% |
| 2021 | -$0.95 | -9.46% |
| 2020 | -$1.05 | -37.29% |
| 2019 | -$1.67 | 21.65% |
| 2018 | -$1.38 | -23.02% |
| 2017 | -$1.79 | -0.79% |
| 2016 | -$1.80 | |
| 2014 | -$0.007121 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -$0.85 | 0.00% | 🇺🇸 USA |
 | $1.05 | -223.33% | 🇺🇸 USA |
 | -$2.48 | 191.67% | 🇮🇱 Israel |